NURO - ヌロメトリックス （NeuroMetrix Inc.）NUROのニュース
NeuroMetrix to Exhibit Quell Fibromyalgia and Present New Clinical Data at the American Academy of Pain Medicine 2023 Annual Meeting 2023/03/21 13:00:00 Wallstreet:Online
WOBURN, Mass., March 21, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) will exhibit Quell Fibromyalgia at the American Academy of Pain Medicine 39th Annual Meeting on March 23 - 26 in Ft. Lauderdale, FL. In addition, two scientific posters reporting new data on the use of Quell in patients with fibromyalgia will be presented. Fibromyalgia is a chronic condition characterized by generalized
NeuroMetrix, Inc. (NURO) Q4 2022 Earnings Call Transcript 2023/02/23 22:23:05 Seeking Alpha
NeuroMetrix, Inc. (NASDAQ:NASDAQ:NURO) Q4 2022 Results Conference Call February 23, 2023 8:00 AM ETCompany ParticipantsThomas Higgins - Senior VP, CFO & TreasurerShai Gozani - Founder,…
NeuroMetrix GAAP EPS of -$0.09, revenue of $1.84N 2023/02/23 12:16:30 Seeking Alpha
NeuroMetrix press release (NURO): Q4 GAAP EPS of -$0.09.Revenue of $1.84M (+1.1% Y/Y).Gross profit in Q4 2022 was $1.2 million, a decrease of 1.0% from the fourth quarter of 2021
NeuroMetrix Reports Q4 and Full Year 2022 Financial Results 2023/02/23 12:00:00 GlobeNewswire
WOBURN, Mass., Feb. 23, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter and full year ended December 31, 2022. The Company''s mission is to reduce the impact of neurological disorders and pain syndromes on individuals and on population health through innovative non-invasive medical devices.
NeuroMetrix, Inc. Announces Date for Fourth Quarter and Full Year 2022 Financial Results Conference Call 2023/02/16 19:58:00 GlobeNewswire
WOBURN, Mass., Feb. 16, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2022 fourth quarter and year end financial results before the opening of the market on February 23, 2023. The Company will host a conference call at 8:00 a.m., Eastern Time on February 23, 2023 to discuss its financial results as well as business developments affecting the Company.
NeuroMetrix to Exhibit Quell Fibromyalgia and Present New Clinical Data at the American Academy of Pain Medicine 2023 Annual Meeting 2023/03/21 13:00:00 Wallstreet:Online
WOBURN, Mass., March 21, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) will exhibit Quell Fibromyalgia at the American Academy of Pain Medicine 39th Annual Meeting on March 23 - 26 in Ft. Lauderdale, FL. In addition, two scientific posters reporting new data on the use of Quell in patients with fibromyalgia will be presented. Fibromyalgia is a chronic condition characterized by generalized
NeuroMetrix, Inc. (NURO) Q4 2022 Earnings Call Transcript 2023/02/23 22:23:05 Seeking Alpha
NeuroMetrix, Inc. (NASDAQ:NASDAQ:NURO) Q4 2022 Results Conference Call February 23, 2023 8:00 AM ETCompany ParticipantsThomas Higgins - Senior VP, CFO & TreasurerShai Gozani - Founder,…
NeuroMetrix GAAP EPS of -$0.09, revenue of $1.84N 2023/02/23 12:16:30 Seeking Alpha
NeuroMetrix press release (NURO): Q4 GAAP EPS of -$0.09.Revenue of $1.84M (+1.1% Y/Y).Gross profit in Q4 2022 was $1.2 million, a decrease of 1.0% from the fourth quarter of 2021
NeuroMetrix Reports Q4 and Full Year 2022 Financial Results 2023/02/23 12:00:00 GlobeNewswire
WOBURN, Mass., Feb. 23, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter and full year ended December 31, 2022. The Company''s mission is to reduce the impact of neurological disorders and pain syndromes on individuals and on population health through innovative non-invasive medical devices.
NeuroMetrix, Inc. Announces Date for Fourth Quarter and Full Year 2022 Financial Results Conference Call 2023/02/16 19:58:00 GlobeNewswire
WOBURN, Mass., Feb. 16, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2022 fourth quarter and year end financial results before the opening of the market on February 23, 2023. The Company will host a conference call at 8:00 a.m., Eastern Time on February 23, 2023 to discuss its financial results as well as business developments affecting the Company.
NeuroMetrix stock dips as Q2 net loss widens, revenue falls Y/Y 2022/07/21 15:16:43 Seeking Alpha
NeuroMetrix (NURO) stock fell ~3% after the company reported a decline in Q2 revenue and a widened net loss.Revenues fell -3.4% Y/Y to to $2.13M Y/Y
NeuroMetrix, Inc. (NURO) CEO Shai Gozani on Q2 2022 Results - Earnings Call Transcript 2022/07/21 15:14:15 Seeking Alpha
NeuroMetrix, Inc. (NASDAQ:NASDAQ:NURO) Q2 2022 Earnings Conference Call July 21, 2022 08:00 ET Company Participants Thomas Higgins - Senior Vice President and Chief Financial Officer Shai…
NeuroMetrix GAAP EPS of -$0.17, revenue of $2.1M 2022/07/21 11:07:18 Seeking Alpha
NeuroMetrix press release (NURO): Q2 GAAP EPS of -$0.17.Revenue of $2.1M (-5.0% Y/Y).
NeuroMetrix Reports Q2 2022 Financial Results 2022/07/21 11:00:00 GlobeNewswire
WOBURN, Mass., July 21, 2022 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter and six months period ended June 30, 2022. The Company''s mission is to reduce the impact of neurological disorders and pain syndromes on individuals and on population health through innovative non-invasive medical devices.
NeuroMetrix, Inc. Announces Date for Second Quarter 2022 Financial Results Conference Call 2022/07/14 15:32:00 GlobeNewswire
WOBURN, Mass., July 14, 2022 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2022 second quarter financial results before the opening of the market on July 21, 2022. The Company will host a conference call at 8:00 a.m., Eastern Time on July 21, 2022 to discuss its financial results as well as business developments affecting the Company.